Startseite UR
Einträge von Schally, Andrew V. auf dem Publikationsserver
 | Eine Stufe nach oben |
Gehe zu: Artikel
Anzahl der Einträge: 8.
Artikel
Seitz, Stephan, Buchholz, Stefan, Schally, Andrew V. 
, Jayakumar, Arumugam R., Weber, Florian, Papadia, Andrea , Rick, Ferenc G. , Szalontay, Luca, Treszl, Andrea, Köster, Frank, Ortmann, Olaf und Hohla, Florian
(2013)
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Anti-Cancer Drugs 24 (2), S. 150-157.
Volltext nicht vorhanden.
, Jayakumar, Arumugam R., Weber, Florian, Papadia, Andrea , Rick, Ferenc G. , Szalontay, Luca, Treszl, Andrea, Köster, Frank, Ortmann, Olaf und Hohla, Florian
(2013)
Targeting triple-negative breast cancer through the somatostatin receptor with the new cytotoxic somatostatin analogue AN-162 [AEZS-124].
Anti-Cancer Drugs 24 (2), S. 150-157.
Volltext nicht vorhanden.
Rick, Ferenc G. , Buchholz, Stefan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Aigner, Elmar, Perez, Roberto, Seitz, Stephan, Block, Norman L. und Hohla, Florian
(2012)
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Cell Cycle 11 (13), S. 2518-2525.
Volltext nicht vorhanden.
, Buchholz, Stefan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Aigner, Elmar, Perez, Roberto, Seitz, Stephan, Block, Norman L. und Hohla, Florian
(2012)
Combination of gastrin-releasing peptide antagonist with cytotoxic agents produces synergistic inhibition of growth of human experimental colon cancers.
Cell Cycle 11 (13), S. 2518-2525.
Volltext nicht vorhanden.
Rick, Ferenc G. , Seitz, Stephan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Buchholz, Stefan, Block, Norman L. und Hohla, Florian
(2012)
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Cell Cycle 11 (22), S. 4203-4210.
Volltext nicht vorhanden.
, Seitz, Stephan, Schally, Andrew V. , Szalontay, Luca, Krishan, Awtar, Datz, Christian, Stadlmayr, Andreas, Buchholz, Stefan, Block, Norman L. und Hohla, Florian
(2012)
GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer.
Cell Cycle 11 (22), S. 4203-4210.
Volltext nicht vorhanden.
Hohla, Florian, Buchholz, Stefan, Schally, Andrew V. , Krishan, Awtar, Rick, Ferenc G. , Szalontay, Luca, Papadia, Andrea , Halmos, Gabor, Koster, Frank, Aigner, Elmar, Datz, Christian und Seitz, Stephan
(2010)
Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
Cancer Letters 294 (1), S. 35-42.
Volltext nicht vorhanden.
, Krishan, Awtar, Rick, Ferenc G. , Szalontay, Luca, Papadia, Andrea , Halmos, Gabor, Koster, Frank, Aigner, Elmar, Datz, Christian und Seitz, Stephan
(2010)
Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
Cancer Letters 294 (1), S. 35-42.
Volltext nicht vorhanden.
Seitz, Stephan, Schally, Andrew V. , Treszl, Andrea, Papadia, Andrea , Rick, Ferenc , Szalontay, Luca, Szepeshazi, Karoly, Ortmann, Olaf, Halmos, Gabor, Hohla, Florian und Buchholz, Stefan
(2009)
Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.
Anti-Cancer Drugs 20 (7), S. 553-558.
Volltext nicht vorhanden.
, Treszl, Andrea, Papadia, Andrea , Rick, Ferenc , Szalontay, Luca, Szepeshazi, Karoly, Ortmann, Olaf, Halmos, Gabor, Hohla, Florian und Buchholz, Stefan
(2009)
Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.
Anti-Cancer Drugs 20 (7), S. 553-558.
Volltext nicht vorhanden.
Köster, Frank, Engel, Jörg B. , Schally, Andrew V. , Hönig, Arnd, Schröer, Andreas, Seitz, Stephan, Hohla, Florian, Ortmann, Olaf, Diedrich, Klaus und Buchholz, Stefan
(2009)
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Breast Cancer Research and Treatment 116 (2), S. 273-279.
Volltext nicht vorhanden.
, Schally, Andrew V. , Hönig, Arnd, Schröer, Andreas, Seitz, Stephan, Hohla, Florian, Ortmann, Olaf, Diedrich, Klaus und Buchholz, Stefan
(2009)
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Breast Cancer Research and Treatment 116 (2), S. 273-279.
Volltext nicht vorhanden.
Buchholz, Stefan, Schally, Andrew V. , Engel, Jörg B. , Hohla, Florian, Heinrich, Elmar, Koester, Frank, Varga, Jozsef L. und Halmos, Gabor
(2007)
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Proceedings of the National Academy of Sciences 104 (6), S. 1943-1946.
Volltext nicht vorhanden.
, Engel, Jörg B. , Hohla, Florian, Heinrich, Elmar, Koester, Frank, Varga, Jozsef L. und Halmos, Gabor
(2007)
Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel.
Proceedings of the National Academy of Sciences 104 (6), S. 1943-1946.
Volltext nicht vorhanden.
Buchholz, Stefan, Keller, Gunhild, Schally, Andrew V. , Halmos, Gabor, Hohla, Florian, Heinrich, Elmar, Koester, Frank, Baker, Benjamin und Engel, Jörg B.
(2006)
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.
Proceedings of the National Academy of Sciences 103 (27), S. 10403-10407.
Volltext nicht vorhanden.
, Halmos, Gabor, Hohla, Florian, Heinrich, Elmar, Koester, Frank, Baker, Benjamin und Engel, Jörg B.
(2006)
Therapy of ovarian cancers with targeted cytotoxic analogs of bombesin, somatostatin, and luteinizing hormone-releasing hormone and their combinations.
Proceedings of the National Academy of Sciences 103 (27), S. 10403-10407.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707